AnalystBook Research · Company Intelligence

DMC Global Inc.

BOOMNasdaq

Built from DMC Global Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

DMC Global revenue fell 5.1% in FY2025, but FCF improved, debt fell, and losses narrowed across a three-segment industrial portfolio.

The read at a glance✓ Audited against SEC data
  • Business mixArcadia, DynaEnergetics, NobelCladNote
  • Revenue$609.8M, -5.1%Watch
  • FCF$37.0M, +26.3%OK
  • LossNet loss narrowed 85.8%OK
  • Debt$50.6M, -28.5%OK
  • Insiders$236.8K purchases / 2 salesNote
  • AccountingAltman grey; Beneish clean; EQ 91.2Note

Business

DMC Global owns three manufacturing businesses: Arcadia Products, DynaEnergetics, and NobelClad.

Where the revenue comes from

Fiscal 2025, as DMC Global Inc. reports it. History and quarterly detail are in the app.

  • DynaEnergetics$270.2M
  • Arcadia Products$246.2M
  • NobelClad$93.4M

Leadership changes

From DMC Global Inc.'s own filings, the day they're filed.

  • Simon M. Bates · Directors · departureeff. 2025-04-30
  • Michelle Shepston · Chief Legal Officer · departureeff. 2025-03-28
  • James O'Leary · President · appointmenteff. 2024-11-29

Latest filings

  • 10-Q · Quarterly report2026-07-29
  • 8-K · Company announcement2026-07-29
  • 8-K · Company announcement2026-05-14
  • 8-K · Company announcement2026-04-30
  • 10-Q · Quarterly report2026-04-30
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about DMC Global Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.